July 16, 2024 — Neurologic complications from long COVID are widespread, difficult to treat, and often debilitating. These symptoms can resemble a variety of conditions, including some as severe as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Postural Orthostatic Tachycardia Syndrome (POTS), making the illness both challenging to diagnose and manage. New research now suggests long COVID may largely be an autonomic nervous system disorder. More and more, long COVID patients

— Phase II trial reveals brigatinib surpasses historical benchmarks by reducing 10% of targeted tumors A Phase II platform trial presented promising findings for patients suffering from NF2-related schwannomatosis with advancing tumors. The ALK inhibitor brigatinib (Alunbrig) demonstrated potential across various tumor types, showing measurable tumor shrinkage and enhancements in hearing, along with improvements in other clinical parameters. Among 40 individuals diagnosed with either vestibular